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Abstract:The Coronavirus-19 pandemic continues at full speed, and the number of 
patients who die from Covıd-19 is increasing. It was aimed to evaluate the 
demographic information and laboratory findings of 86 patients who died while being 
followed up in our hospital with a pre-diagnosis of Covıd-19. Identifying these 
characteristics of deceased patients will be essential to guide clinicians in identifying 
critically ill patients. Data on demographic information, comorbidities, time from 
hospitalization to death, molecular test results, thorax CT findings, biochemical 
findings, culture, antibiotic susceptibility, and the given treatments of the cases were 
collected from the electronic system Kastamonu Training and Research Hospital. 
While the RT-PCR test of 21 of the cases was positive, in 9 of the cases, control 
PCR tests were negative after a while. The CT results of 18 of the 21 initially RT-
PCR positive cases were compatible with Covid-19, and the CT result of 3 could not 
be reached. When the blood test results of the cases were examined, neutrophil 
increase, white blood cell increase, lymphocyte reduction, and inflammatory markers 
increase were determined. A total of 43 bacterial growths were found in 21 cases. It 
has been observed that deaths in patients who were followed up with the pre-
diagnosis of Covıd-19 generally occur in older people, males, and those with 
underlying diseases. It was thought that the cause of death could be underlying 
diseases, pathologies caused by inflammation, and secondary bacterial infections in 
addition to viral infection. Clinicians should be more careful about elderly patients, 
patients with secondary bacterial infections, or patients with neutrophilia, 
lymphopenia. 
Keywords:Covıd-19; mortality risk factors; lymphopenia. 
 
INTRODUCTION 
 Covıd-19 is a disease caused by a new coronavirus that first appeared in 
December 2019. It has different characteristics from other coronaviruses, so there 
are unknown factors about the course of the disease, diagnostic methods, and 
treatment (Velavan et al., 2020). By 27 August 2020, in the world and Turkey, 
respectively, 24,021,218 and 263 998 cases; 821 462 and 6209 deaths have been 
reported (Cakir, 2020). 
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The gold standard in diagnosing Covıd-19 is the demonstration of viral nucleic acid 
by reverse transcriptase-polymerase chain reaction (RT-PCR) in samples from the 
upper and lower respiratory tract (Erensoy S, 2020). Ground glass opacity, flagstone 
appearance, and consolidation in chest CT of patients with suspected Covıd-19 are 
evaluated as findings in favor of Covıd-19. However, although the sensitivity of chest 
CT is high (67-100%) in the diagnosis of Covıd-19, its specificity (25-80%) is low 
(Kovacs et al., 2020).  
Publications are stating that mortality is higher in men, older people, and 
those with underlying diseases (such as hypertension, coronary artery disease, 
diabetes,  malignancy) (Zhoue et al., 2020; Qiu et al., 2020; Zhang et al., 2020; Zhao 
et al., 2020). The hallmark of severe Covıd-19 is the hyperinflammatory host 
response known as the "cytokine storm," an uncontrolled systemic inflammatory 
response that results from the release of large amounts of pro-inflammatory 
cytokines. The inflammation that develops with the cytokine storm starts locally and 
then spreads to the whole body through the circulation; It causes multiple organ 
failures, rapidly developing respiratory distress, and death due to extensive tissue 
damage. Depending on the cytokine storm, lymphopenia has also been reported with 
increased inflammatory markers such as ferritin, troponin, LDH, CRP, and D-dimer. 
Sometimes, bacterial infections are also observed in these patients, leading to 
increased morbidity and mortality (Li et al., 2020; Hu et al., 2020). There are studies 
on the characteristics of patients who died due to covid worldwide, but such a study 
from Turkey has not yet been published. We aimed to compare the data of other 
countries by analyzing the data in our country. This study aimed to evaluate the 
demographic information and laboratory findings of 86 patients who died while being 
followed up in our hospital with a pre-diagnosis of Covıd-19. 
 
MATERIALS AND METHODS 
86 cases who died while being followed up with the pre-diagnosis of Covıd-19 
in Kastamonu Training and Research Hospital (Kastamonu, Turkey)  between 
24.03.2020-09.08.2020 were included in the study. This study was approved by the 
Kastamonu Training and Research Hospital Ethics Committee (Date: 04.12.2020, 
decision no: 2020-KAEH-143-01.01). 
Real-time RT-qPCR method for Covıd-19 
Viral RNA analysis was performed with real-time quantitative PCR (RT-qPCR) 
on a nasopharyngeal swab. RT-qPCR test kits for Covıd-19 are provided by the 
Turkey General Directorate of Public Health. The method was studied in line with the 
recommendations of the Bio-eksen firm. First of all, viral nucleic acid isolation was 
made to prepare templates. For this, 100 µl of the swab samples received in Viral 
Transport Medium (VTM) was taken and added to the tube containing 100 µl vNAT 
(Viral Nucleic Acid Isolation Kit (Bio-Speedy). The tube was vortexed for 15 seconds 
at the highest speed. After 5 minutes of incubation at room temperature, it was used 
as a template. 
The reagents included in the Covıd-19 RT-qPCR Detection Kit (Bio-Speedy) 
were prepared according to the company recommendations and distributed to the 
PCR plate as 15 µL per bowl, 5 µL template was added on it. 
The plates were cycled in the C1000 Touch Thermal Cycler CFX96 Real-Time 
System (BioRad, UK) device once at 45°C for 15 minutes, once at 95°C for 3 
minutes; 50 times at 95°C for 5 seconds and at 55°C for 35 seconds. While 
interpreting the results, the shape of the growth curves obtained in the FAM/HEX 
channels was examined. Non-sigmoidal curves were considered harmful. If the 
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threshold value was set to 200 and the calculated threshold cycle number was 38-
40≤Cq according to the lot studied, it was considered positive. When it was above 
these values, the test was repeated. 
Imaging Technique and Radiological Evaluation 
 All patients underwent CT scanning 16 MSCT Alexion Advance scanner with 
thick slice 4 mm routinely (Toshiba, 2014, Netherlands). Images were acquired using 
the following parameters 130 kVp; 100–200 mAs; pitch, 0.75-1.5; and collimation, 
0.625--5 mm, FOV 44x44. CT examination was performed without using contrast 
media. The position of the patients was supine, and the procedure was performed 
after full inspiration. All images were examined with both lung (width, 1200 HU; 
Center, −600 HU) and mediastinal (width, 400 HU; Center, 40 HU) windows. 
The North American Society of Radiology (RSNA), the Society of Thoracic 
Radiology, and the American College of Radiology (ACR) classified computed 
tomography (CT) findings for Covıd-19 into four categories ( Jaegere et al., 2020). 
Unlike this, we gathered those whose CT findings were non-specific and had no 
findings in CT in one group and evaluated the cases in three main groups. 
 Typical Classical Group (Group I): Ground glass opacity (GGO) has been 
considered indispensable for every patient in this group. In addition to GGO,  
consolidation,  peripheral distribution, and bilateral involvement were strong findings 
in favor of Covıd-19. 
Unidentified (intermediate) Group (Group II): Includes the following findings 
without GGO, which are only consolidation, central distribution, mosaic perfusion, 
including airway wall thickening, bronchiectasis, other abnormalities, presence of 
underlying lung disease such as emphysema or  fibrosis,  including linear opacities, 
opacities with rounded morphology, opacities with a reverse halo sign, opacities with 
a crazy-paving pattern 
 Non-Covıd Group (Group III): This group has ambiguous, non-specific 
findings; pleural effusion, pericardial fluid, nodules but GGO and GGO plus 
consolidation is never viewed. In some patients in this group, CT findings were 
completely normal. 
Other data 
The patients' culture and antibiotic susceptibility tests were performed using 
the conventional Vıtek (Biomerieux, France) method and evaluated according to 
Eucast standards. Colistin results were excluded from evaluation according to 
Eucast standards. 
Demographic information, comorbidities, time from hospitalization to death, 
molecular test results, thoracic CT findings, biochemical findings, culture, and 
antibiotic susceptibility test results, and the treatments of the cases applied were 
collected from the hospital's electronic system. 
Statistical analysis 
 Categorical variables are defined using frequencies and percentages, while 
continuous variables are defined using mean and median values. Continuous 
measures such as mean (SD) and categorical variables are reported as numbers 
and percentages (%). SPSS (version 22.0) was used for all analyzes. 
  
RESULTS AND DISCUSSION 
 Our study observed that 86 (7,35%) of 1169 patients who were 
followed up with the pre-diagnosis of Covıd-19 at that time died, but it was not shown 
that the cause of death of all these patients was Covıd-19. 
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Of the death cases, 59 (68.6%) were male, 27 (31,4%) were female. The cases are 
between 35-96; the average age is 72, and the median age is 75. The hospitalization 
to death of the cases ranged from 0 to 70 days, and the median was six days. The 
demographic characteristics of the death cases are presented in Table 1. 
 
Table 1: Demographic Characteristics of the Dead Cases 
¹: Cardiovascular disease 
²: Diabetes mellitus 
³: Chronic obstructive pulmonary disease 
⁴: Chronic kidney disease 
 
Table 2. PCR and CT Results of the 86 Cases Analyzed 
1 PCR positive patients who became negative later 
 
Covıd-19 antibody tests of ten cases were examined, and only one of them 
was found positive. The Covıd-19 RT-qPCR result of all the cases whose antibody 
tests were examined was negative. Looking at the CT results of these cases, in the 
case with a positive Covıd -19 antibody test, BT was found to be compatible with 
Covıd-19. While the CT result of 8 of the cases with negative Covıd-19 antibody 
Features Total Percent 
Age Average 72  
Subgroups <40 years 2 %2,32 
40-49 years 5 %5,81 
50-59 years 10 %11,62 
60-69 years 12 %13,95 
70-79 years 29 %33,72 
80-89 years 23 %26,74 
90-96 years 5 %5,81 
Gender Male 59 %68,6 
Female 27 %31,4 
Underlying disease Hypertension 21 %24,4 
CVD1 16 %18,6 
DM2 13 %15,1 
COPD3 13 %15,1 
Malignancy 10 %11,6 
CKD4 8 %9,3 
Comorbidity 
association 
0 Comorbidity 40 %46,52 
1 Comorbidity 21 %24,4 
2 Comorbidity 13 %15,1 






(Group 1)  










 (n = 27) 
 
PCR (+) (n=21) 9+9¹ 0 0 3 
PCR (-) (n=65) 33 7 1 24 
Total 51 7 1 27 
Medical Laboratory Technology Journal |  
 
Copyright © 2021, MLTJ, ISSN 2461-0879 
 
tests was compatible with Covıd-19, the CT result of one was compatible with the 
intermediate case. 
 Laboratory findings of the death cases at the time of admission to the hospital 
and in the last 24 hours before they died are shown in Table 3. When the blood 
tables of the cases were examined,  respectively, on the day of hospitalization and in 
the last 24 hours, the neutrophil increase was 63% and 69%, white blood cell 
increase was 41% and 64%, while lymphocyte reduction was 52% and 45%. When 
the inflammatory markers of the cases were evaluated on the day of hospitalization 
and in the last 24 hours, respectively; CRP increase was 97% and 95%,LDH 
increase was 76% and 84%; D-dimer increase was 87% and 98%; ferritin increase 
was 41% and 64%; troponin increase was 72% and 91%. There was also an 
increase in the median values of inflammatory markers. 
 
Table 3. Laboratory Findings of the Cases on the day of Hospitalization and in the 
Last 24 Hours before They Died. 
 
  
When the culture results of the death cases were examined, it was found that there 
was a total of 43 bacterial growth in 21 cases (24.41%). Growing bacteria and 
clinical specimens with growth are shown in Table 4. Five of these patients had a 
positive Covıd-19 RT-PCR result, one of five became negative during follow-up, and 
16 had a negative result. When the resistance profiles of the bacteria grown were 
examined, 20 of the 43 bacterial growths were caused by the persistent bacteria, 
and they were from 13 patients in total. It has been observed that treatment options 
are available for other bacterial growths. 
Biochemical Findings Findings on the 
day of 
hospitalization 
Findings of the 




Average 11,12x10³ 16,17x10³ 
<3,5x10³ 6 (%8,45) 4 (%5,47) 
3,5-10,5x10³ 36 (%50,70) 22 (%30,13) 
>10,5x10³ 29 (%40,84) 47 (%64,38) 
Neutrophil Average 9,44x10³ 14,18x10³ 
<1,7x10³ 2 (%2,81) 2 (%2,77) 
1,7-7x10³ 24 (%33,80) 20 (%27,77) 
>7x10³ 45 (%63,38) 50 (%69,44) 
Lymphocyte Average 1,06x10³ 1,16x10³ 
<0,9x10³ 37 (%52,11) 33 (%45,83) 
0,9-2,9x10³ 32 (%45,07) 37 (%51,38) 
>2,9x10³ 2 (%2,81) 2 (%2,77) 
CRP Median 103 125 
>5 70 (%97,22) 70 (%95,89) 
LDH Median 344 420 
>248 53 (%76,81) 58 (%84,25) 
D-dimer Median 3,85 7,05 
>0,55 63 (%87,5) 66 (%98,50) 
Ferritin Median 202 573 
E:>336, k:>307 29 (%41,42) 44 (%64,70) 
Troponin Median 42 135 
E:>19, K:>11,6 52 (%72,22) 67 (%91,78) 
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 Six (6.97%) of 86 cases were followed up in Covıd -19 wards and 80 
(93.03%) in intensive care units. The treatments received by the cases from the day 
of hospitalization to the death of the cases are shown in Table 5. At least one 
antiviral and hydroxychloroquine was started in all cases during their hospitalization. 
Antibiotics were given to 98.61% of the cases to treat or prevent secondary bacterial 
infection. Glucocorticoids were given to 25 patients, and IL-6 inhibitors were given to 
12 patients to suppress the severe inflammatory response. 
 











A.baumanii 8 4  12 
K.pneumonia 6 1 6 13 
E.faecium   2 2 
E.coli  1 1 2 
P.aeruginosa   1 1 
S.aureus  4  4 
S.maltophilia  1  1 
Total 14 11 10 35 
 
 
Table 5. Treatments Received by Cases 
 
Treatment Total (n=72) 
Hydroxychloroquine 54 (%75) 
Antibiotic 71 (%98,61) 
Antiviral 51 (%70,83) 
Antifungal 11 (%15,27) 
Glucocorticoid 25 (%34,72) 
IL-6 inhibitor (Tocilizumab) 12 (%16,6) 
 
In this retrospective study, 86 cases who died while being followed up with a 
pre-diagnosis of Covıd-19 in our hospital were analyzed.Our study observed that 
men died more frequently, similar to other studies(Zhou et al., 2020; Zhang et al., 
2020). Studies link women's resistance to viral infections to the effects of the X 
chromosome and sex hormones on the immune system, which play an essential role 
in adaptive immunity (Jaillon et al., 2019). The average age of the dead cases was 
found to be 72 in our study, and studies are reporting that the average age of the 
dead cases is between 68 and 75.5, in line with us.(Zhou et al., 2020; Zhang et al., 
2020). Chronic diseases increase with aging. Besides, increased age-related 
functional defects in immunological cells such as T and B cells and excessive 
production of type 2 cytokines can cause prolonged pro-inflammatory responses, 
leading to a worse course of possible infections. (Bektas et al., 2017; Chung et al., 
2019). 
In our study, 53.48% of the cases had comorbidities. In other studies, it was 
observed that 44.9-100% of the death cases had at least one comorbidity, and the 
frequency was in the form of hypertension (64-38%), diabetes (18-40%), and 
coronary heart disease (16-32%); and was compatible with our study(Zhoue et al., 
2020; Qiu et al., 2020; Zhang et al., 2020; Zhao et al., 2020). In addition to 
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endothelial dysfunction, a pro-inflammatory state occurs in chronic diseases, 
weakening the innate immune response. For example, in diabetes, the synthesis of 
pro-inflammatory cytokines and acute-phase reactants such as interferon-gamma 
and interleukins is reduced. The host's innate and humoral immune systems are 
functionally impaired. Besides, metabolic disorders can disrupt macrophage and 
lymphocyte function, leading to reduced immune function, making individuals more 
susceptible to disease complications. (Yang et al., 2020). Angiotensin-converting 
enzyme 2 (ACE2) plays a role in binding and entering SARS-CoV2 into host cells. 
When the lung samples of patients with severe Covıd-19 and comorbidities were 
examined, a higher presentation of ACE2 was found in these patients than in control 
subjects (Pinto et al., 2020). These findings may explain why patients with 
comorbidities experience severe Covıd-19. 
In our case group, who died while RT-PCR was positive, the frequency of 
cases proven to have died due to Covıd-19 was 14%. When evaluated with CT 
findings, it is observed that 51 cases are compatible with Covıd-19 and all RT-PCR 
positive cases are in this group. On the other hand, the CT findings of 42 cases, 
including 9 RT-PCR (+) cases and subsequently became negative, were compatible 
with Covıd -19, while PCR results were negative. Since CT is a low specificity test in 
the diagnosis of Covıd -19 and other respiratory viral agents are not sought, the 
cause of death of these patients is not clear, and other viral factors may be among 
the causes. Interpretation is not possible with CT for intermediate cases, non-
compliant cases, and those without CT results. Looking at similar studies, in a study 
that evaluated 85 cases who were clinically diagnosed with Covıd-19 and died, it 
was observed that 38.8% of the cases were positive for the Covıd-19 RT-PCR test, 
and 97.5% of the CT findings were compatible with Covıd-19(Du et al., 2020). In 
another study, it was stated that 95% of 264 cases were diagnosed with Covıd-19 
clinically, the Covıd-19 RT-PCR test was positive, 88% of CT findings were 
compatible with Covıd-19(Colombi et al., 2020). The percentage of RT-PCR 
positivity in these studies was higher than in our study. On the other hand, the 
percentage of the CT findings of the first study being compatible with Covıd-19 was 
found to be higher than PCR positivity, and in this respect, it was similar to our study. 
When looking at the results of antibody tests, the case found to be positive is likely to 
be Covıd-19, as the CT finding also supports it, but the cause of death has not been 
proven. 
In our study, the median time from hospitalization to death of the cases was 
found to be six days. In other studies, the average time from the onset of symptoms 
to death was found to be 9-22.3 days. (Zhou et al., 2020; Zhang et al., 2020; Li et al., 
2020). In our study, the onset of symptoms could not be reached, and the time from 
hospitalization to death was calculated, explaining the shorter duration. 
In this study, changes were also observed in the blood picture of the patients 
(Table 3). One of them, lymphopenia, is a prominent feature in critically ill patients 
with Covıd-19 infection. Several mechanisms are likely to cause this condition: 
lymphocytes present the coronavirus receptor ACE2 and can become direct targets 
for the virus, resulting in direct lymphocyte death; pro-inflammatory cytokines 
possibly causing lymphocyte apoptosis; Molecules produced as a result of metabolic 
disorders such as lactic acidemia may lead to inhibition of lymphocytes. The 
resulting lymphopenia can lead to death by creating a cellular immune deficiency 
state(Tan et al., 2020). Also, studies have shown that the neutrophil-lymphocyte ratio 
(NLR) used as an inflammation marker is associated with clinical worsening and 
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mortality in Covıd-19 patients (Liu et al., 2020). Our findings are also consistent with 
these studies. 
When the other laboratory findings of the cases were examined, it was 
observed that there was an increase in the levels of CRP, LDH, D-dimer, ferritin, and 
troponin (Table 3). Covıd-19 can directly damage the lung epithelium, as a result of 
which monocytes and macrophages increase, levels of pro-inflammatory cytokines 
such as interleukin (IL) 6, IL-1, tumor necrosis factor (TNF) α, and IL-8 are 
exaggerated, and “cytokine storm" may cause. Cytokine storms may play an 
essential role in the aggravation of the disease, causing severe acute respiratory 
distress syndrome. CRP, cardiac troponin, D-dimer, and LDH levels, which are the 
markers stimulated by the release of cytokines, are indicators of tissue and organ 
inflammation, cardiac damage, coagulation abnormalities, tissue damage, 
respectively, and have been associated with poor prognosis(Henry et al., 2020; Kiss 
et al., 2020). Studies have shown that leukocytosis, lymphopenia, and inflammatory 
markers such as CRP, D-dimer, LDH, and ferritin increase in most deaths, and 
systemic inflammation leads to lung and multi-organ dysfunction, especially in high-
risk patients (Chung et al., 2019). When we look at the inflammatory markers of the 
cases in our study, it was high on the day of hospitalization and increased more in 
the process. Based on these findings and the suggestions of other studies, it was 
thought that some of the patients in the risky group who died might have died due to 
various organ damage, especially respiratory and heart, and even their failure as a 
result of inflammation. 
When the simultaneous growing culture samples of the deceased cases were 
examined, it was observed that pan-resistant bacteria were grown in 20 clinical 
samples belonging to 13 cases. All of these cases have negative RT-PCR results. 
Considering that clinical samples are in the form of the respiratory tract, blood, and 
urine in these cases, the cause of death may be a bacterial infection. In studies 
examining cases hospitalized with the diagnosis of Covıd-19, it was observed that 
bacterial growth was detected in the blood and respiratory samples of the cases, 
varying between 6.1-37%. In these studies, it was observed that Acinetobacter 
baumanii from gram-negative bacteria and Staphylococcus aureus among gram-
positive bacteria were the most frequently produced bacteria according to us(Ripa et 
al., 2020; Yu et al., 2020; Dudoignon et al., 2020; Hugher et al., 2020). 95.34% of the 
cases in our study died in the ICU. Hospitalization of Covıd-19 patients in the ICU is 
an indication that the disease is getting worse. However, due to the need for invasive 
treatments in the ICU, co-infection risks increase. Therefore, empirical broad-
spectrum antibacterial and antifungal treatments were initiated in these patients. 
However, broad-spectrum antibiotics can lead to the emergence of multidrug-
resistant bacteria. In these patients, steroids are also initiated to alleviate the 
inflammatory response in the lungs, which increases the risk of secondary infection. 
When looking at the studies examining the treatments given to patients with 
Covıd-19, it was found that 63.9-70% of the patients were given antibiotics, 62.4-
76% antivirals, and 19-33% glucocorticoids. (Chen et al., 2020; Wong et al., 2020). 
In our study, it is observed that these drugs were given. It forms the basis of antiviral 
therapy. Hydroxychloroquine was widely used when the disease first started to 
appear. Antibiotics and antifungal agents were added against the risk of secondary 
infection or added for treatment in bacterial growth. Glucocorticoids and IL-6 
inhibitors (tocilizumab) were added to protect the patient from the damage of the 
cytokine storm(Zhao et al., 2020). 
Medical Laboratory Technology Journal |  
 
Copyright © 2021, MLTJ, ISSN 2461-0879 
 
As a result, it was thought that the causes of death of Covıd-19 patients might 
be underlying causes, pathologies caused by inflammation, and secondary bacterial 
infections in addition to viral infection.The study's limitations are that there is no 
control group from Covid-19 patients living in our study, and the sample size does 
not include more patients. 
 
CONCLUSION 
Most of the patients who died due to Covid-19 are elderly, have an underlying 
chronic disease, and have increased inflammatory markers.In addition, bacterial 
growth was detected in some of them, and the cause of death may be due to 
secondary bacterial infection.It is recommended that clinicians consider these 
situations when evaluating Covıd-19 patients and prioritize the care of critically ill 
patients accordingly. 
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